Publications en collaboration avec des chercheurs de National Institute of Allergy and Infectious Diseases (48)

2024

  1. Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays

    PLoS Pathogens, Vol. 20, Núm. 9

  2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  3. Purification and analysis of kidney-infiltrating leukocytes in a mouse model of lupus nephritis

    Methods in Cell Biology (Academic Press Inc.), pp. 131-152

2023

  1. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)–associated inflammatory diseases

    Journal of Allergy and Clinical Immunology, Vol. 136, Núm. 5, pp. 1337-1345

2014

  1. Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation

    Journal of Allergy and Clinical Immunology, Vol. 134, Núm. 5, pp. 1190-1193.e1

2013

  1. Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy

    Clinical and Experimental Immunology, Vol. 173, Núm. 1, pp. 131-139

2012

  1. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells

    Blood, Vol. 119, Núm. 12, pp. 2799-2809

  2. Leukocyte-associated Ig-like receptor-1 - Deficient mice have an altered immune cell phenotype

    Journal of Immunology, Vol. 188, Núm. 2, pp. 548-558

2011

  1. CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection

    Blood, Vol. 117, Núm. 22, pp. 5870-5880

  2. Complex regulation of human NKG2D-DAP10 cell surface expression: Opposing roles of the γc cytokines and TGF-β1

    Blood, Vol. 118, Núm. 11, pp. 3019-3027

  3. Cutting edge: Mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis

    Journal of Immunology, Vol. 187, Núm. 7, pp. 3483-3487

2010

  1. Human Th1 Cells That Express CD300a Are Polyfunctional and After Stimulation Up-Regulate the T-Box Transcription Factor Eomesodermin

    PLoS ONE, Vol. 5, Núm. 5

2009

  1. A single residue, arginine 65, is critical for the functional interaction of leukocyte-associated inhibitory receptor-1 with collagens

    Journal of Immunology, Vol. 182, Núm. 9, pp. 5446-5452

  2. Endocytosis and intracellular trafficking of human natural killer cell receptors

    Traffic, Vol. 10, Núm. 12, pp. 1735-1744

  3. Endocytosis as a mechanism of regulating natural killer cell function: Unique endocytic and trafficking pathway for CD94/NKG2A

    Immunologic Research, Vol. 43, Núm. 1-3, pp. 210-222